Martina Garau

986 total citations
30 papers, 516 citations indexed

About

Martina Garau is a scholar working on Economics and Econometrics, General Health Professions and Management of Technology and Innovation. According to data from OpenAlex, Martina Garau has authored 30 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Economics and Econometrics, 4 papers in General Health Professions and 3 papers in Management of Technology and Innovation. Recurrent topics in Martina Garau's work include Health Systems, Economic Evaluations, Quality of Life (28 papers), Pharmaceutical Economics and Policy (19 papers) and Intellectual Property and Patents (3 papers). Martina Garau is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (28 papers), Pharmaceutical Economics and Policy (19 papers) and Intellectual Property and Patents (3 papers). Martina Garau collaborates with scholars based in United Kingdom, United States and Switzerland. Martina Garau's co-authors include Jorge Mestre-Ferrándiz, Jon Sussex, Adrian Towse, Alastair Kent, Adam Hutchings, Claude Schmitt, Koonal Shah, Asja Fischer, Alec Miners and Dogan Fidan and has published in prestigious journals such as BMJ, Value in Health and Orphanet Journal of Rare Diseases.

In The Last Decade

Martina Garau

29 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martina Garau United Kingdom 10 394 107 68 39 34 30 516
Jens Grueger United States 6 262 0.7× 54 0.5× 29 0.4× 25 0.6× 20 0.6× 16 374
Eline van Overbeeke Belgium 14 322 0.8× 151 1.4× 75 1.1× 85 2.2× 45 1.3× 26 674
Arno Brandt Switzerland 8 196 0.5× 88 0.8× 22 0.3× 17 0.4× 7 0.2× 21 407
M Drummond United Kingdom 9 196 0.5× 91 0.9× 19 0.3× 26 0.7× 13 0.4× 23 320
Tara Schuller Canada 7 397 1.0× 218 2.0× 24 0.4× 79 2.0× 7 0.2× 12 499
Sheela Upadhyaya United Kingdom 11 174 0.4× 82 0.8× 105 1.5× 52 1.3× 38 1.1× 24 446
Bernarda Zamora United Kingdom 10 213 0.5× 115 1.1× 38 0.6× 24 0.6× 9 0.3× 36 358
Tomáš Tesař Slovakia 14 249 0.6× 54 0.5× 53 0.8× 23 0.6× 11 0.3× 49 440
Chiara Whichello United States 9 250 0.6× 141 1.3× 31 0.5× 47 1.2× 16 0.5× 25 432
Michele Pistollato United Kingdom 7 147 0.4× 135 1.3× 36 0.5× 72 1.8× 7 0.2× 17 387

Countries citing papers authored by Martina Garau

Since Specialization
Citations

This map shows the geographic impact of Martina Garau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina Garau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina Garau more than expected).

Fields of papers citing papers by Martina Garau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina Garau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina Garau. The network helps show where Martina Garau may publish in the future.

Co-authorship network of co-authors of Martina Garau

This figure shows the co-authorship network connecting the top 25 collaborators of Martina Garau. A scholar is included among the top collaborators of Martina Garau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martina Garau. Martina Garau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Gayathri S., et al.. (2025). Navigating change: a comparative analysis of health technology assessment reforms across agencies – processes, drivers, and interdependencies. International Journal of Technology Assessment in Health Care. 41(1). e21–e21. 1 indexed citations
2.
Mott, David, et al.. (2023). Resource allocation in public sector programmes: does the value of a life differ between governmental departments?. Cost Effectiveness and Resource Allocation. 21(1). 96–96. 2 indexed citations
3.
Largeron, Nathalie, et al.. (2023). OP137 A Qualitative Exploration Of The National Institute For Health And Care Excellence’s Impact On International Health Technology Assessment. International Journal of Technology Assessment in Health Care. 39(S1). S40–S40. 1 indexed citations
4.
Garau, Martina, et al.. (2020). Are Cost-Effectiveness Thresholds fit for Purpose for Real-World Decision Making?. RePEc: Research Papers in Economics. 5 indexed citations
5.
Zamora, Bernarda, F. Maignen, P. O’Neill, Jorge Mestre-Ferrándiz, & Martina Garau. (2019). Comparing access to orphan medicinal products in Europe. Orphanet Journal of Rare Diseases. 14(1). 95–95. 66 indexed citations
6.
Towse, Adrian & Martina Garau. (2018). Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence. RePEc: Research Papers in Economics. 4 indexed citations
7.
Towse, Adrian, et al.. (2018). Multi-Indication Pricing (MIP): Practical Solutions and Steps to Move Forward. RePEc: Research Papers in Economics. 5 indexed citations
8.
Zamora, Bernarda, Martina Garau, F. Maignen, P. O’Neill, & Jorge Mestre-Ferrándiz. (2017). OP138 Access To Orphan Drugs In The United Kingdom And Other European Countries. International Journal of Technology Assessment in Health Care. 33(S1). 64–65. 5 indexed citations
9.
10.
Moloney, Rachael, Penny Mohr, Emma Hawe, et al.. (2015). PAYER PERSPECTIVES ON FUTURE ACCEPTABILITY OF COMPARATIVE EFFECTIVENESS AND RELATIVE EFFECTIVENESS RESEARCH. International Journal of Technology Assessment in Health Care. 31(1-2). 90–98. 14 indexed citations
11.
Garau, Martina, et al.. (2015). IS THE LINK BETWEEN HEALTH AND WEALTH CONSIDERED IN DECISION MAKING? RESULTS FROM A QUALITATIVE STUDY. International Journal of Technology Assessment in Health Care. 31(6). 449–456. 6 indexed citations
12.
Hernández-Villafuerte, K., Martina Garau, & Nancy Devlin. (2014). Do Nice Decisions Affect Decisions in Other Countries?. Value in Health. 17(7). A418–A418. 5 indexed citations
13.
Sussex, Jon, et al.. (2013). A Pilot Study of Multicriteria Decision Analysis for Valuing Orphan Medicines. Value in Health. 16(8). 1163–1169. 85 indexed citations
14.
Sussex, Jon, et al.. (2013). Multi-Criteria Decision Analysis to Value Orphan Medicines. RePEc: Research Papers in Economics. 11 indexed citations
15.
Garau, Martina, Koonal Shah, Anne Mason, et al.. (2011). Using QALYs in Cancer. PharmacoEconomics. 29(8). 673–685. 71 indexed citations
16.
Garau, Martina, Adrian Towse, & Patricia M. Danzon. (2011). Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution?. SSRN Electronic Journal. 4 indexed citations
17.
Garau, Martina & Jorge Mestre-Ferrándiz. (2009). Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries Briefing. SSRN Electronic Journal. 9 indexed citations
18.
Buxton, Iain L. O., Stephen Hanney, Stephen Morris, et al.. (2008). Medical Research: What's It Worth? Estimating the Economic Benefits from Medical Research in the UK. 82 indexed citations
19.
Garau, Martina & Jon Sussex. (2007). Estimating Pharmaceutical Companies’ Value to the National Economy - Case Study of the British Pharma Group. SSRN Electronic Journal. 3 indexed citations
20.
Miners, Alec, Martina Garau, Dogan Fidan, & Asja Fischer. (2004). Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study. BMJ. 330(7482). 65–65. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jens Grueger Breakdown of academic impact, for papers by Eline van Overbeeke Breakdown of academic impact, for papers by Arno Brandt Breakdown of academic impact, for papers by M Drummond Breakdown of academic impact, for papers by Tara Schuller Breakdown of academic impact, for papers by Sheela Upadhyaya Breakdown of academic impact, for papers by Bernarda Zamora Breakdown of academic impact, for papers by Tomáš Tesař Breakdown of academic impact, for papers by Chiara Whichello Breakdown of academic impact, for papers by Michele Pistollato
Rankless by CCL
2026